180O IMpassion132 double-blind randomised phase III trial of chemotherapy (CT) ± atezolizumab (atezo) for early-relapsing unresectable locally advanced or metastatic triple-negative breast cancer (aTNBC)
Authors:
- R.A. DentRDR.A. Dent
- F. AndréFAF. André
- A. GonçalvesAGA. Gonçalves
- M. Martin JimenezMJM. Martin Jimenez
- P. SchmidPSP. Schmid
- F. SchützFSF. Schütz
- S. KummelSKS. Kummel
- S.M. SwainSSS.M. Swain
- A. BiliciABA. Bilici
- D. LoiratDLD. Loirat
- R. Villalobos ValenciaRVR. Villalobos Valencia
- S-A. ImSIS-A. Im
Open Access